Amphetamine Screening
Individual amphetamine screening with laboratory confirmation.
Add to your order
No referral needed
Added to your order
Click the button to view your cart
Included Substances
1 substancesAmphetamines
This test screens for the presence of amphetamines in urine. Detection is typically possible within a window of approximately two to four days after use, though individual variation may occur.
Why this test?
This screening detects amphetamines and related compounds in urine. The approximate detection window is two to four days, though this may vary depending on individual factors such as metabolism, hydration, and dosage. It is worth noting that certain prescription medications, including some used for ADHD, may contain amphetamine-based compounds and could produce a positive screening result.
Who is this test for?
This test may be relevant for:
- Individuals who wish to verify the presence or absence of amphetamines for their own information
- People who need a focused, single-substance screening for amphetamines
- Anyone seeking documentation of an amphetamine-specific screening result
What is tested?
This test measures a single marker:
- Amphetamines: measured in urine, expressed in ug/l. The test detects the presence of amphetamine and related compounds above the laboratory's reporting threshold. The approximate detection window is two to four days. Note: some prescription medications (such as certain ADHD medications) contain amphetamine-based compounds and may produce a positive result.
What can this test tell you?
A positive result indicates that amphetamines were detected above the laboratory's reporting threshold, suggesting that the substance may have been present in the body within the detection window. A negative result means that amphetamines were not detected above the threshold at the time of sample collection.
If a positive result is obtained, confirmation testing may be performed. It may be relevant to mention any prescription medications to a healthcare provider, as some medications can influence the screening outcome. The test provides information about detection or non-detection and does not indicate dosage or frequency of use.
How is the sample collected?
The test requires a urine sample, collected at a certified sample point (afnamepunt). A mid-stream sample is collected under the guidance of trained personnel. The process is straightforward and typically takes only a few minutes.
When is this test useful?
This test may be considered when:
- A focused screening for amphetamines is desired
- Personal insight into whether amphetamines are present is wanted
- Documentation of an amphetamine-specific screening result is needed
What do the results mean?
The result is reported as detected or not detected. A positive result suggests that amphetamine use may have occurred within the approximate detection window (two to four days). A negative result indicates that the substance was not found above the reporting threshold.
Individual factors such as metabolism, hydration, and prescription medication use may influence the result. If you take prescription medications that contain amphetamine-based compounds, this information may be relevant when discussing results with a healthcare provider.
Preparation
Collect a mid-stream urine sample at the sample point. Hydrate normally beforehand. Over-hydration may dilute the sample and could affect the reliability of the result. If you take prescription medications that could affect the screening, you may wish to note this for reference when discussing results with a healthcare provider.
What happens after the results?
Results are typically available within a few working days. The report indicates whether amphetamines were detected or not detected.
If the initial screening produces a positive result, confirmation testing using a more specific analytical method may be performed. The final report includes the confirmed outcome. A healthcare provider can help interpret the results in context, particularly if prescription medications may have influenced the screening.
Frequently Asked Questions
This screening uses laboratory immunoassay technology designed to detect amphetamines and related compounds. Detection windows typically range from 2-4 days after use, though this may vary based on individual factors and the specific compound.
What We Screen For
| No. | Biomarker | Unit | Turnaround |
|---|---|---|---|
| 01 | Amphetamines | ug/l | 4 days |
| Your result arrives once the slowest test is finished: 4 days. This is indicative; turnaround varies per laboratory. | |||
Preparation
Nothing special is needed for these tests.
- Water is always fine. Drink as usual beforehand, it makes the draw easier.
- Take your usual medication, unless your own doctor told you otherwise.
Extend this panel
Same draw, no second appointment.
Related Panels
Alcohol (CDT) Test
A CDT test measures chronic alcohol use over recent weeks. The Dutch guideline sets the cut-off at 2.0%.
Cocaine Screening
Individual cocaine metabolite screening with laboratory confirmation.
Ketamine Screening
Individual ketamine metabolite screening with laboratory confirmation.